# Yunhezhiyao

AI target discovery, RNA sequence optimization, and small nucleic acid drug development



Canonical: https://uniquebase.ai/companies/UB-C6135
Stable identifier: UB-C6135
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T20:54:47.668Z

## Funding

Listed 2 records.

- 2026-09-22 · amount unavailable · Equity · 光华梧桐, 晓池资本, 梧桐聚云企管, 瑞尚医药
  > On September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma. (translated source brief)
- 2025-08-05 · Undisclosed · Series A · 恩然创投

## Valuation

Listed 2 records.

- 2026-09-22 · amount unavailable · Equity · 光华梧桐, 晓池资本, 梧桐聚云企管, 瑞尚医药
  > On September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma. (translated source brief)
- 2025-08-05 · amount unavailable · Series A · 恩然创投

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

No published products profiles are linked yet.

## Investors

- [光华梧桐](/institutions/guanghuawutong)
- [恩然创投](/institutions/enran-venture-capital)
- [晓池资本](/institutions/xiaochi-capital)
- [梧桐聚云企管](/institutions/wutongjuyunqiguan)
- [瑞尚医药](/institutions/ruishang-pharmaceutical)

## Sources

- No source links are available for this profile.